Linda Wase

Internal Medicine

19 Winged Foot Ct
Skillman, NJ 08558

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Budget impact and pharmacy costs with targeted use of oliceridine for postsurgical pain in patients at high risk of opioid-related adverse events.

Budget impact and pharmacy costs with targeted use of oliceridine for postsurgical pain in patients at high risk of opioid-related adverse events.

Journal: Expert review of pharmacoeconomics & outcomes research

Published: February 07, 2022

Cost-effectiveness and cost-benefit analysis of oliceridine in the treatment of acute pain.

Cost-effectiveness and cost-benefit analysis of oliceridine in the treatment of acute pain.

Journal: Journal of comparative effectiveness research

Published: July 09, 2021

Oliceridine Exhibits Improved Tolerability Compared to Morphine at Equianalgesic Conditions: Exploratory Analysis from Two Phase 3 Randomized Placebo and Active Controlled Trials.

Oliceridine Exhibits Improved Tolerability Compared to Morphine at Equianalgesic Conditions: Exploratory Analysis from Two Phase 3 Randomized Placebo and Active Controlled Trials.

Journal: Pain and therapy

Published: June 04, 2021

Low Incidence of Opioid-Induced Respiratory Depression Observed with Oliceridine Regardless of Age or Body Mass Index: Exploratory Analysis from a Phase 3 Open-Label Trial in Postsurgical Pain.

Low Incidence of Opioid-Induced Respiratory Depression Observed with Oliceridine Regardless of Age or Body Mass Index: Exploratory Analysis from a Phase 3 Open-Label Trial in Postsurgical Pain.

Journal: Pain and therapy

Published: November 04, 2020

Oliceridine is Associated with Reduced Risk of Vomiting and Need for Rescue Antiemetics Compared to Morphine: Exploratory Analysis from Two Phase 3 Randomized Placebo and Active Controlled Trials.

Oliceridine is Associated with Reduced Risk of Vomiting and Need for Rescue Antiemetics Compared to Morphine: Exploratory Analysis from Two Phase 3 Randomized Placebo and Active Controlled Trials.

Journal: Pain and therapy

Published: September 23, 2020

Evaluating the Incidence of Opioid-Induced Respiratory Depression Associated with Oliceridine and Morphine as Measured by the Frequency and Average Cumulative Duration of Dosing Interruption in Patients Treated for Acute Postoperative Pain.

Evaluating the Incidence of Opioid-Induced Respiratory Depression Associated with Oliceridine and Morphine as Measured by the Frequency and Average Cumulative Duration of Dosing Interruption in Patients Treated for Acute Postoperative Pain.

Journal: Clinical drug investigation

Published: June 26, 2020

Oliceridine, a G protein-selective ligand at the μ-opioid receptor, for the management of moderate to severe acute pain.

Oliceridine, a G protein-selective ligand at the μ-opioid receptor, for the management of moderate to severe acute pain.

Journal: Drugs of today (Barcelona, Spain : 1998)

Published: April 21, 2020

Low Incidence of Postoperative Respiratory Depression with Oliceridine Compared to Morphine: A Retrospective Chart Analysis.

Low Incidence of Postoperative Respiratory Depression with Oliceridine Compared to Morphine: A Retrospective Chart Analysis.

Journal: Pain research & management

Published: April 03, 2020

ATHENA: A Phase 3, Open-Label Study Of The Safety And Effectiveness Of Oliceridine (TRV130), A G-Protein Selective Agonist At The µ-Opioid Receptor, In Patients With Moderate To Severe Acute Pain Requiring Parenteral Opioid Therapy.

ATHENA: A Phase 3, Open-Label Study Of The Safety And Effectiveness Of Oliceridine (TRV130), A G-Protein Selective Agonist At The µ-Opioid Receptor, In Patients With Moderate To Severe Acute Pain Requiring Parenteral Opioid Therapy.

Journal: Journal of pain research

Published: May 30, 2019

Assessment, stratification, and monitoring of the risk for prescription opioid misuse and abuse in the primary care setting.

Assessment, stratification, and monitoring of the risk for prescription opioid misuse and abuse in the primary care setting.

Journal: Journal of opioid management

Published: February 11, 2012

Effectiveness and safety of morphine sulfate extended-release capsules in patients with chronic, moderate-to-severe pain in a primary care setting.

Effectiveness and safety of morphine sulfate extended-release capsules in patients with chronic, moderate-to-severe pain in a primary care setting.

Journal: Journal of pain research

Published: November 18, 2011

Showing 1-11 of 11

Last Updated: 09/26/2026